This study systematically investigated the role of mPGES-PGE2-EP4 pathway in mastitis pathogenesis during E. coli infection and evaluated the therapeutic value of mPGES-1 inhibitors (MF63, MK886) and EP4 receptor antagonists (Grapiprant). Here, PTGER4 is linked to escherichia coli infection.